RN7SL764P

Across TCGA pan-cancer cohorts, RN7SL764P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RN7SL764P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RN7SL764P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SL764P expression acts as an unfavorable survival marker, although some lineages such as STAD and SKCM show a favorable association.

ACC, KIRC, and CESC are the cancer types where RN7SL764P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	All	0.010	0.667	<.001	135	view →
KIRC	DFS	Tertile	IV	0.181	0.364	.017	54	view →
CESC	OS	Tertile	III,IV	0.176	0.668	.005	54	view →
LUSC	OS	Tertile	III,IV	0.348	0.694	.013	36	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	27	view →
STAD	OS	Quartile	IV	0.748	0.199	.023	21	view →
READ	DFS	Tertile	III,IV	0.182	0.745	.012	18	view →
LIHC	OS	Tertile	III,IV	0.125	0.624	<.001	18	view →
SKCM	OS	Tertile	III,IV	1.000	0.800	.026	9	view →
THCA	OS	Tertile	All	0.620	0.931	.028	9	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RN7SL764P–ACC (DFS)

Open the ACC breakdown →